Autoimmune sensorineural hearing loss (ASNHL) is the most common cause of sudden hearing loss in adults and is typically characterized by a bilateral, rapidly progressive hearing deficit that responds therapeutically to corticosteroid treatment. Despite its name, data implicating autoimmunity in the etiopathogenesis of ASNHL have been limited, and targeted self-antigens have not been identified. We have recently shown that ASNHL patients have increased frequencies of inner ear-specific interferon-gamma- producing T cells in their peripheral blood compared to age- and sex-matched control subjects. Thus, inner ear-specific proinflammatory T cells appear to be implicated in the etiopathogenesis of ASNHL. Moreover, we have found that a targeted T cell response to defined inner ear specific peptides is capable of mediating hearing loss in SWXJ mice. In the current application, our working hypothesis is that ASNHL is at least in part a T cell-mediated organ-specific autoimmune disorder of the inner ear. Our proposed experiments are designed to identify and characterize the hierarchy of inner ear-specific target antigens and T cell repertoires involved in the development, progression, and immunoregulation of both human ASNHL and its murine counterpart. The significance of ASNHL as opposed to other forms of hearing loss resides in its potential for medical intervention. We believe that our proposed experimental design will substantially advance our understanding of ASNHL and thereby provide a basis for developing contemporary immunomodulatory therapies that may dramatically change and improve treatment of this debilitating hearing disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Research Project (R01)
Project #
5R01DC006422-05
Application #
7737346
Study Section
Special Emphasis Panel (ZRG1-IFCN-B (02))
Program Officer
Watson, Bracie
Project Start
2005-12-05
Project End
2011-11-30
Budget Start
2009-12-01
Budget End
2011-11-30
Support Year
5
Fiscal Year
2010
Total Cost
$311,501
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Gasser Rutledge, Krysta L; Prasad, Kumar G; Emery, Kara R et al. (2015) Short-term Peripheral Auditory Effects of Cranial Irradiation: A Mouse Model. Ann Otol Rhinol Laryngol 124:903-10
Czerny, Mary S; Namin, Arya; Gratton, Michael Anne et al. (2014) Histopathological and clinical analysis of chronic rhinosinusitis by subtype. Int Forum Allergy Rhinol 4:463-9
Buniel, Maria C; Geelan-Hansen, Katie; Weber, Peter C et al. (2009) Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy 1:425-34
Altuntas, Cengiz Z; Daneshgari, Firouz; Liu, Guiming et al. (2008) Bladder dysfunction in mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 203:58-63
Liu, Jinbo; Lin, Feng; Strainic, Michael G et al. (2008) IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J Immunol 180:5882-9
Lin, Yi-Hao; Liu, Guiming; Kavran, Michael et al. (2008) Lower urinary tract phenotype of experimental autoimmune cystitis in mouse: a potential animal model for interstitial cystitis. BJU Int 102:1724-30
Jane-wit, Daniel; Altuntas, Cengiz Z; Monti, Jennifer et al. (2008) Sex-defined T-cell responses to cardiac self determine differential outcomes of murine dilated cardiomyopathy. Am J Pathol 172:11-21
Tuohy, Vincent K; Altuntas, Cengiz Z (2007) Autoimmunity and premature ovarian failure. Curr Opin Obstet Gynecol 19:366-9
Jane-wit, Daniel; Altuntas, Cengiz Z; Johnson, Justin M et al. (2007) Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation 116:399-410
Altuntas, Cengiz Z; Johnson, Justin M; Tuohy, Vincent K (2006) Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure. J Immunol 177:1988-96

Showing the most recent 10 out of 12 publications